Back

Polypharmacy and deprescribing: integrating age and comorbidity

31 August 2026 (13:12 - 13:24)
Organised by: Logo
Congress Presentation Part of: Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation Cardiovascular Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marie Blanquet

University Hospital Gabriel Montpied, Clermont-Ferrand (France)

4 More presentations in this session

Presentation thumbnail
Global medication safety and polypharmacy: a World Health Organization perspective
Professor G. Parati (Milan, IT)
Presentation thumbnail
Artificial intelligence for managing polypharmacy: from prediction to clinical decision support
Professor T. Grodzicki (Cracow, PL)
Presentation thumbnail
Polypharmacy and drug persistence - patient perspective
Doctor M. Van Heetvelde (Gent, BE)
Presentation thumbnail
Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation - discussion

Access the full session

Session thumbnail
Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation

The Event

Event poster

ESC Congress 2026

31 August 2026 13:12 CET
You may be interested in
thumbnail
Congress Presentation
Manage multimorbidity and polypharmacy
3 April 2025
thumbnail
Congress Presentation
Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
30 August 2020
thumbnail
Congress Presentation
Deprescribing in older patients with chronic heart failure and atrial fibrillation
29 June 2021
thumbnail
Webinar
How to manage elderly patients with atrial fibrillation and multiple comorbidities
12 November 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources